Close

AstraZeneca (AZN) Announces Significant Data from Bydureon Combo Phase 3 in T2D Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. SNAP
9. TMUS
10. BSX


Go back to AstraZeneca (AZN) Announces Significant Data from Bydureon Combo Phase 3 in T2D Patients
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 75.03 +3.83 (5.38%)
Previous Close $71.20    52 Week High $35.04 
Open $74.99    52 Week Low $26.97 
Day High $75.81    P/E N/A 
Day Low $74.50    EPS $0.00 
Volume 15,569,046